US 8,802,710 B2Granted

Metronidazole esters for treating rosacea

AssigneeGalderma Research & Development

InventorsJean-Guy Boiteau, Jean-Michel Linget

Life of this patent

Estimating the term…

A compound of formula (I): is described, as well as enantiomers, pharmaceutically acceptable salts thereof, and uses thereof.

Dependent claims

A compound of formula (I) below:

Dependencies are inferred from the claim text.

C07D 233/94
Attached in position 4 or 5: with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to other ring members
A61K 9/0014
Galenical forms characterised by the site of application: skin, i.e. galenical aspects of topical compositions
A61K 31/4164
Having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole: 1,3-Diazoles
A61P 17/00
Drugs for dermatological disorders

From the US filing history. Foreign family members aren’t listed.

Loading patent…